Invention Grant
US07767201B2 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same
有权
血管细胞遗传改变以过表达血管生成增殖和成熟因子; 用同样的方法治疗动脉粥样硬化
- Patent Title: Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same
- Patent Title (中): 血管细胞遗传改变以过表达血管生成增殖和成熟因子; 用同样的方法治疗动脉粥样硬化
-
Application No.: US10429093Application Date: 2003-05-02
-
Publication No.: US07767201B2Publication Date: 2010-08-03
- Inventor: Moshe Y. Flugelman , Zoya Gluzman , Meir Preis , Belly Koren , Tzafra Cohen , Adili Tsaba , Anat Weisz
- Applicant: Moshe Y. Flugelman , Zoya Gluzman , Meir Preis , Belly Koren , Tzafra Cohen , Adili Tsaba , Anat Weisz
- Applicant Address: IL Nazareth
- Assignee: Multi-Gene Vascular Systems Ltd.
- Current Assignee: Multi-Gene Vascular Systems Ltd.
- Current Assignee Address: IL Nazareth
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi; Matthew Pavao
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/85
Abstract:
This invention relates to a method for producing angiogenesis in a tissue of a patient by administering vascular cells genetically altered to over-express an angiogenic proliferation factor and an angiogenic maturation factor to the affected tissue.
Public/Granted literature
Information query
